Hythiam, Inc. (HYTM) has announced that the company’s PROMETA Treatment Program is scheduled to be featured on ABC News’ Nightline this evening at 11:30 p.m. local time. Additionally, the PROMETA Treatment Program will be featured on CBS Television’s 60 Minutes … Continue reading →

According to the U.S. Centers for Disease Control and Prevention’s (CDC) most recent statistics, obesity is the number one health threat facing Americans, killing about 400,000 people each year with medical and other costs tipping the scale near $123 billion … Continue reading →

As technology advances leaps and bounds, one thing becomes blazingly clear; the general public, including the average investor, is often unable to fully understand just what the technology “does”. This isn’t just an isolated incident comprised of a group of … Continue reading →

Uranium Energy is a junior resource company focused on becoming a near-term In-Situ Recovery (ISR) uranium producer in the United States. The operational management consists of uranium mining and exploration professionals whose collective experience in the uranium mining industry gives … Continue reading →

Vertical Branding, Inc. announced that its revenue increased from $5.3 million to $9.1 million for the third quarter of this year, a 71% increase. The retail distribution segment contributed $5.7M of the revenue for the quarter, which is an extraordinary … Continue reading →

Grubb & Ellis Company’s (GBE) shareholders have approved an acquisition by privately-held NNN Realty Advisors Inc, a leading commercial real estate service company. Initially, both companies agreed to this share exchange in June, specifying that NNN shareholders will be granted … Continue reading →

Hoku Scientific, Inc. (HOKU) announced that the company has signed a non-binding term sheet agreement with Merrill Lynch for the company’s wholly owned subsidiary, Hoko Materials Inc. Per the terms of this agreement, Hoku will able to borrow approximately $185 … Continue reading →

Lexicon Pharmaceuticals, Inc. (LXRX) has announced that the company has commenced Phase 2a clinical trial for their LX6171 drug, a prevalent oral drug candidate. This drug will treat cognitive impairment, often associated with disorders such as Alzheimer’s disease, schizophrenia, and … Continue reading →

Move, Inc (MOVE), a leading online real estate search engine utilization company, has signed an exclusive, three year content distribution agreement with MSN. As a result, more than 94.8 million monthly MSN visitors will continue to have instant access to … Continue reading →

Dynatronics Corporation (DYNT) announced that the company’s Board of Directors have approved an additional $250,000 designated for their open market share repurchase program. Dynatronics expects to make all purchases when cash from operations and their overall line of credit allow. … Continue reading →